{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T15:42:49Z","timestamp":1774366969263,"version":"3.50.1"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007514","name":"University of Pisa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007514","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.bpg.2023.101830","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T09:52:39Z","timestamp":1678960359000},"page":"101830","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Nutritional intervention in the management of non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"62-63","author":[{"given":"Maurizia R.","family":"Brunetto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Salvati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Petralli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9942-0328","authenticated-orcid":false,"given":"Ferruccio","family":"Bonino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpg.2023.101830_bib1","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.cgh.2018.05.057","article-title":"Global non-alcoholic steato-hepatitis council. Non-Alcoholic steato-hepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates","volume":"17","author":"Younossi","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2023.101830_bib2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2023.101830_bib3","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2023.101830_bib4","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2023.101830_bib5","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.bpg.2023.101830_bib6","article-title":"Auto-brewery syndrome: a clinical dilemma","volume":"12","author":"Tameez-Ud-Din","year":"2020","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.bpg.2023.101830_bib7","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/liv.14430","article-title":"Redefining fatty liver disease classification in 2020","volume":"40","author":"Valenti","year":"2020","journal-title":"Liver Int"},{"issue":"9","key":"10.1016\/j.bpg.2023.101830_bib8","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1111\/liv.14620","article-title":"MAFLD vs NAFLD: let the contest begin","volume":"40","author":"Bianco","year":"2020","journal-title":"Liver Int"},{"issue":"9","key":"10.1016\/j.bpg.2023.101830_bib9","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1111\/liv.14548","article-title":"Comparison of MAFLD and NAFLD diagnostic criteria in real world","volume":"40","author":"Lin","year":"2020","journal-title":"Liver Int"},{"issue":"30","key":"10.1016\/j.bpg.2023.101830_bib10","doi-asserted-by":"crossref","first-page":"4999","DOI":"10.3748\/wjg.v27.i30.4999","article-title":"Brain-gut-liver interactions across the spectrum of insulin resistance in metabolic fatty liver disease","volume":"27","author":"Rebelos","year":"2021","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bpg.2023.101830_bib11","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease","volume":"64","author":"Marchesini","year":"2016","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.bpg.2023.101830_bib12","article-title":"Non-alcoholic fatty liver disease: a patient guideline","volume":"3","author":"Francque","year":"2021","journal-title":"JHEP Rep"},{"issue":"4","key":"10.1016\/j.bpg.2023.101830_bib13","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","article-title":"Treatment of NAFLD with diet, physical activity and exercise","volume":"67","author":"Romero-G\u00f3mez","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2023.101830_bib14","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/liv.14360","article-title":"The role of nutrition in non-alcoholic fatty liver disease: pathophysiology and management","volume":"40","author":"Genoveva Bern\u00e1","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.bpg.2023.101830_bib15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.metabol.2016.12.006","article-title":"Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: a meta-analysis","volume":"68","author":"Katsagoni","year":"2017","journal-title":"Metabolism"},{"issue":"9","key":"10.1016\/j.bpg.2023.101830_bib16","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.3390\/nu13093135","article-title":"Positive effects of exercise intervention without weight loss and dietary changes in NAFLD-related clinical parameters: a systematic review and meta-analysis","volume":"13","author":"Babu","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.bpg.2023.101830_bib17","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.clnu.2013.11.003","article-title":"Diets and nonalcoholic fatty liver disease: the good and the bad","volume":"33","author":"Asrih","year":"2014","journal-title":"Clin Nutr"},{"issue":"1","key":"10.1016\/j.bpg.2023.101830_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0007114520000914","article-title":"Food groups and the likelihood of non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"124","author":"He","year":"2020","journal-title":"Br J Nutr"},{"key":"10.1016\/j.bpg.2023.101830_bib19","first-page":"468","article-title":"Improving dietary patterns in patients with nonalcoholic fatty liver disease","volume":"15","author":"Carvalhana","year":"2012","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.bpg.2023.101830_bib20","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.metabol.2015.03.008","article-title":"A review of potential metabolic etiologies of the observed association between red meat consumption and development of type 2 diabetes mellitus","volume":"64","author":"Kim","year":"2015","journal-title":"Metabolism"},{"issue":"7","key":"10.1016\/j.bpg.2023.101830_bib21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/qjmed\/hcv172","article-title":"Associations of sugar- and artificially sweetened soda with nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"109","author":"Wijarnpreecha","year":"2016","journal-title":"QJM"},{"issue":"4","key":"10.1016\/j.bpg.2023.101830_bib22","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s40519-016-0315-3","article-title":"Beverage consumption and pediatric NAFLD","volume":"21","author":"Mosca","year":"2016","journal-title":"Eat Weight Disord"},{"issue":"8","key":"10.1016\/j.bpg.2023.101830_bib23","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1017\/S0007114516003391","article-title":"Dietary sodium and potassium intake in relation to non-alcoholic fatty liver disease","volume":"116","author":"Choi","year":"2016","journal-title":"Br J Nutr"},{"issue":"8","key":"10.1016\/j.bpg.2023.101830_bib24","first-page":"1007","article-title":"Relationship between diet and non-alcoholic fatty liver disease: a review article","volume":"46","author":"Mirmiran","year":"2017","journal-title":"Iran J Public Health"},{"key":"10.1016\/j.bpg.2023.101830_bib25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.nutres.2017.04.002","article-title":"Long-term soft drink and aspartame intake induces hepatic damage via dysregulation of adipocytokines and alteration of the lipid profile and antioxidant status","volume":"41","author":"Lebda","year":"2017","journal-title":"Nutr Res"},{"issue":"5","key":"10.1016\/j.bpg.2023.101830_bib26","first-page":"28","article-title":"Soft drinks consumption and the risk of nonalcoholic fatty liver disease","volume":"65","author":"Siddiqi","year":"2017","journal-title":"J Assoc Phys India"},{"issue":"5","key":"10.1016\/j.bpg.2023.101830_bib27","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jhep.2018.01.019","article-title":"Fructose and sugar: a major mediator of non-alcoholic fatty liver disease","volume":"68","author":"Jensen","year":"2018","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.bpg.2023.101830_bib28","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.3390\/nu13051442","article-title":"Overview of non-alcoholic fatty liver disease (NAFLD) and the role of sugary food consumption and other dietary components in its development","volume":"13","author":"Vancells Lujan","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.bpg.2023.101830_bib29","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1210\/jc.2019-00160","article-title":"Overeating saturated fat promotes fatty liver and ceramides compared with polyunsaturated fat: a randomized trial","volume":"104","author":"Rosqvist","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bpg.2023.101830_bib30","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.2337\/dc18-0071","article-title":"Saturated fat is more metabolically harmful for the human liver than unsaturated fat or simple sugars","volume":"41","author":"Luukkonen","year":"2018","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.bpg.2023.101830_bib31","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.clnu.2014.01.018","article-title":"Mediterranean diet and non-alcoholic fatty liver disease: the need of extended and comprehensive interventions","volume":"34","author":"Trovato","year":"2015","journal-title":"Clin Nutr"},{"issue":"11","key":"10.1016\/j.bpg.2023.101830_bib32","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.3390\/nu10111577","article-title":"The combined effect of promoting the mediterranean diet and physical activity on metabolic risk factors in adults: a systematic review and meta-analysis of randomized controlled trials","volume":"10","author":"Malakou","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.bpg.2023.101830_bib33","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1249\/MSS.0000000000001901","article-title":"Physical activity and sedentary time: association with metabolic health and liver fat","volume":"51","author":"Bowden Davies","year":"2019","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.bpg.2023.101830_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.716783","article-title":"Dietary interventions in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"8","author":"Houttu","year":"2021","journal-title":"Front Nutr"},{"key":"10.1016\/j.bpg.2023.101830_bib35","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1016\/j.clnu.2020.09.001","article-title":"ESPEN practical guideline: clinical nutrition in liver disease","volume":"39","author":"Bischoff","year":"2020","journal-title":"Clin Nutr"},{"issue":"3","key":"10.1016\/j.bpg.2023.101830_bib36","first-page":"404","article-title":"Epidemiology of nonalcoholic fatty liver disease in Europe: a systematic review and meta-analysis","volume":"34","author":"Cholongitas","year":"2021","journal-title":"Ann Gastroenterol"},{"issue":"18","key":"10.1016\/j.bpg.2023.101830_bib37","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1017\/S1368980018002707","article-title":"Association between fast-food consumption and lifestyle characteristics in Greek children and adolescents; results from the EYZHN (National Action for Children's Health) programme","volume":"21","author":"Tambalis","year":"2018","journal-title":"Publ Health Nutr"},{"key":"10.1016\/j.bpg.2023.101830_bib38","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12876-022-02222-z","article-title":"Empirically derived dietary pattern and odds of non-alcoholic fatty liver diseases in overweight and obese adults: a case\u2013control study","volume":"22","author":"Talenezhad","year":"2022","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"10.1016\/j.bpg.2023.101830_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0007114520000914","article-title":"Food groups and the likelihood of non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"124","author":"He","year":"2020","journal-title":"Br J Nutr"},{"key":"10.1016\/j.bpg.2023.101830_bib40","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/09637486.2016.1214239","article-title":"Mediterranean diet and nonalcoholic fatty liver disease: molecular mechanisms of protection","volume":"68","author":"Godos","year":"2017","journal-title":"Int J Food Sci Nutr"},{"key":"10.1016\/j.bpg.2023.101830_bib41","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.dld.2019.06.005","article-title":"Dietary vitamin E and C intake is inversely associated with the severity of nonalcoholic fatty liver disease","volume":"51","author":"Ivancovsky-Wajcman","year":"2019","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.bpg.2023.101830_bib42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.nfs.2020.08.003","article-title":"Protective effects of extra virgin olive oil against storage-induced omega 3 fatty acid oxidation of algae oil","volume":"21","author":"Gonz\u00e1lez-Hedstr\u00f6m","year":"2020","journal-title":"NFS Journal"},{"key":"10.1016\/j.bpg.2023.101830_bib43","article-title":"Higher phenolic acid intake independently associates with lower prevalence of insulin resistance and non-alcoholic fatty liver disease","volume":"2","author":"Salomone","year":"2020","journal-title":"JHEP Rep"},{"issue":"7","key":"10.1016\/j.bpg.2023.101830_bib44","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.3390\/nu13072381","article-title":"Coffee consumption and the progression of NAFLD: a systematic review","volume":"13","author":"Sewter","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.bpg.2023.101830_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2020.08.071","article-title":"The effect of coffee consumption on the non-alcoholic fatty liver disease and liver fibrosis: a meta-analysis of 11 epidemiological studies","volume":"20","author":"Hayat","year":"2021","journal-title":"Ann Hepatol"},{"issue":"10","key":"10.1016\/j.bpg.2023.101830_bib46","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrgastro.2012.156","article-title":"The role of the gut microbiota in nutrition and health","volume":"9","author":"Flint","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.bpg.2023.101830_bib47","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/10408398.2020.1733483","article-title":"The impact of probiotics, prebiotics, and synbiotics on the biochemical, clinical, and immunological markers, as well as on the gut microbiota of obese hosts","volume":"61","author":"da Silva","year":"2021","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"1","key":"10.1016\/j.bpg.2023.101830_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2020.1779002","article-title":"Modulation of gut microbiota in healthy rats after exposure to nutritional supplements","volume":"12","author":"\u010coklo","year":"2020","journal-title":"Gut Microb"},{"issue":"9","key":"10.1016\/j.bpg.2023.101830_bib49","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.3390\/nu14091773","article-title":"A low glycemic index mediterranean diet combined with aerobic physical activity rearranges the gut microbiota signature in NAFLD patients","volume":"14","author":"Calabrese","year":"2022","journal-title":"Nutrients"},{"issue":"15","key":"10.1016\/j.bpg.2023.101830_bib50","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.3390\/ijms22158161","article-title":"The role of leaky gut in nonalcoholic fatty liver disease: a novel therapeutic target","volume":"22","author":"Kessoku","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"19","key":"10.1016\/j.bpg.2023.101830_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911689","article-title":"Current research on the pathogenesis of NAFLD\/NASH and the gut-liver Axis: gut microbiota, dysbiosis, and leaky-gut syndrome","volume":"23","author":"Kobayashi","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.bpg.2023.101830_bib52","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota","volume":"63","author":"Fizanne","year":"2016","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.bpg.2023.101830_bib53","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/hep.28572","article-title":"Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach","volume":"65","author":"Del Chierico","year":"2017","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.bpg.2023.101830_bib54","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3390\/nu12030820","article-title":"Gut microbiota dysbiosis in patients with biopsy-proven nonalcoholic fatty liver disease: a cross-sectional study in taiwan","volume":"12","author":"Tsai","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.bpg.2023.101830_bib55","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","article-title":"Genetics and epigenetics of NAFLD and NASH: clinical impact","volume":"68","author":"Eslam","year":"2018","journal-title":"J Hepatol"},{"issue":"15","key":"10.1016\/j.bpg.2023.101830_bib56","doi-asserted-by":"crossref","first-page":"8805","DOI":"10.3390\/ijms23158805","article-title":"The effects of probiotics, prebiotics and synbiotics in non-alcoholic fat liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): a systematic review","volume":"23","author":"Carpi","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.bpg.2023.101830_bib57","doi-asserted-by":"crossref","first-page":"81","DOI":"10.5114\/aoms.2016.62150","article-title":"Bifidobacteria and lactobacilli in the gut microbiome of children with non-alcoholic fatty liver disease: which strains act as health players?","volume":"14","author":"Nobili","year":"2018","journal-title":"Arch Med Sci"},{"issue":"1","key":"10.1016\/j.bpg.2023.101830_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5114\/ceh.2019.83151","article-title":"Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease","volume":"5","author":"Augustyn","year":"2019","journal-title":"Clin Exp Hepatol"},{"issue":"24","key":"10.1016\/j.bpg.2023.101830_bib59","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.3390\/nu14245261","article-title":"The prevalence of small intestinal bacterial overgrowth in patients with non-alcoholic liver diseases: NAFLD, NASH, fibrosis, cirrhosis-A systematic review, meta-analysis and meta-regression","volume":"14","author":"Gudan","year":"2022","journal-title":"Nutrients"},{"issue":"24","key":"10.1016\/j.bpg.2023.101830_bib60","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.3390\/nu14245323","article-title":"Gut microbiota in non-alcoholic fatty liver disease patients with inflammatory bowel diseases: a complex interplay","volume":"14","author":"Abenavoli","year":"2022","journal-title":"Nutrients"},{"issue":"24","key":"10.1016\/j.bpg.2023.101830_bib61","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.3390\/nu14245323","article-title":"Gut microbiota in non-alcoholic fatty liver disease patients with inflammatory bowel diseases: a complex interplay","volume":"14","author":"Abenavoli","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.bpg.2023.101830_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.756299","article-title":"Dextran sulfate sodium salt-induced colitis aggravates gut microbiota dysbiosis and liver injury in mice with non-alcoholic steatohepatitis","volume":"12","author":"Shen","year":"2021","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.bpg.2023.101830_bib63","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/livers2010005","article-title":"Anti-inflammatory dietary approach to prevent the development and progression of non-alcoholic fatty liver diseases","volume":"2","author":"Portius","year":"2022","journal-title":"Liver"},{"issue":"6","key":"10.1016\/j.bpg.2023.101830_bib64","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/apt.15416","article-title":"Review article: can bugs be drugs? The potential of probiotics and prebiotics as treatment for non-alcoholic fatty liver disease","volume":"50","author":"Koopman","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.bpg.2023.101830_bib65","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/advances\/nmaa144","article-title":"Does personalized nutrition advice improve dietary intake in healthy adults? A systematic review of randomized controlled trials","volume":"12","author":"Jinnette","year":"2021","journal-title":"Adv Nutr"},{"key":"10.1016\/j.bpg.2023.101830_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.669307","article-title":"Afman LA personalized nutrition","volume":"8","author":"Blaak","year":"2021","journal-title":"Front Nutr"},{"issue":"21","key":"10.1016\/j.bpg.2023.101830_bib67","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.3390\/nu14214465","article-title":"Digital biomarkers for personalized nutrition: predicting meal moments and interstitial glucose with non-invasive, wearable technologies","volume":"14","author":"van den Brink","year":"2022","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.bpg.2023.101830_bib68","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jhep.2018.06.024","article-title":"Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. EASL Clinical Practice Guidelines on nutrition in chronic liver disease","volume":"70","year":"2019","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.bpg.2023.101830_bib69","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1016\/j.clnu.2020.09.001","article-title":"ESPEN practical guideline: clinical nutrition in liver disease","volume":"39","author":"Bischoff","year":"2020","journal-title":"Clin Nutr"},{"issue":"34","key":"10.1016\/j.bpg.2023.101830_bib70","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"ESC national cardiac societies; ESC scientific document group. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.bpg.2023.101830_bib71","volume":"41","author":"Cosentino","year":"2019","journal-title":"European Heart Journal 2019"},{"key":"10.1016\/j.bpg.2023.101830_bib72","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12937-015-0022-3","article-title":"Diet in irritable bowel syndrome","volume":"14","author":"El-Salhy","year":"2015","journal-title":"Nutr J"},{"issue":"6","key":"10.1016\/j.bpg.2023.101830_bib73","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1053\/j.gastro.2021.12.248","article-title":"AGA clinical practice update on the role of diet in irritable bowel syndrome: expert review","volume":"162","author":"Chey","year":"2022","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.bpg.2023.101830_bib74","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.clnu.2016.12.027","article-title":"ESPEN guideline: clinical nutrition in inflammatory bowel disease","volume":"36","author":"Forbes","year":"2017","journal-title":"Clin Nutr"},{"issue":"1","key":"10.1016\/j.bpg.2023.101830_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5493\/wjem.v11.i1.1","article-title":"Role of diet and nutrition in inflammatory bowel disease","volume":"11","author":"de Castro","year":"2021","journal-title":"World J Exp Med"},{"issue":"20","key":"10.1016\/j.bpg.2023.101830_bib76","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.3390\/nu14204261","article-title":"Dietary interventions in inflammatory bowel disease","volume":"14","author":"Godala","year":"2022","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.bpg.2023.101830_bib77","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.dld.2015.10.027","volume":"48","author":"Petta","year":"2016","journal-title":"Dig Liver Dis"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691823000082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691823000082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:04:47Z","timestamp":1761498287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691823000082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":77,"alternative-id":["S1521691823000082"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2023.101830","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nutritional intervention in the management of non-alcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpg.2023.101830","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101830"}}